Came across WIRED: Exin Therapeutics connected an AI agent to a stereotactic injection rig, letting the model perform gene therapy brain injections in live epileptic mice.
Key details: The model chose the treatment, brain region, and dose from 19 candidate vectors; Claude Opus 5.5 refused to make the injection, so they switched to Claude Sonnet 5. They also tested GPT-6.1 Sol and Grok 4.7, which each chose different brain regions. There was human approval and an emergency stop; the mice are reportedly recovering, but it’s too early to say whether the treatment helps with seizures.
AI has moved from writing plans to controlling real lab equipment—the guardrails in labs need to be strengthened accordingly.
#AI #Claude
Key details: The model chose the treatment, brain region, and dose from 19 candidate vectors; Claude Opus 5.5 refused to make the injection, so they switched to Claude Sonnet 5. They also tested GPT-6.1 Sol and Grok 4.7, which each chose different brain regions. There was human approval and an emergency stop; the mice are reportedly recovering, but it’s too early to say whether the treatment helps with seizures.
AI has moved from writing plans to controlling real lab equipment—the guardrails in labs need to be strengthened accordingly.
#AI #Claude
